跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,987 条关于
“Sortilin receptor”
全部
11,987
临床试验
5,728
药物
1,310
机构
30
资讯
4,919
2年前
Vesper Bio's VES001 Shows Promise in Phase I Trial for Frontotemporal Dementia
去年
Sudocetaxel Zendusortide Shows Promise in Advanced Ovarian Cancer Phase 1b Trial
去年
ProteinQure Secures $11M Series A to Advance First AI-Designed Peptide Therapeutic for Triple-Negative Breast Cancer
去年
Alector Announces Strategic Priorities for 2025, Highlights Neurodegenerative Disease Programs
去年
Alector's Phase 3 FTD Trial Misses Primary Endpoint Despite FDA-Endorsed Statistical Plan Amendment
9个月前
Triple-Negative Breast Cancer Pipeline Expands with 170+ Emerging Therapies Across Multiple Development Phases
2年前
FDA Grants Breakthrough Therapy Designation to Latozinemab for FTD-GRN
去年
Vesper Bio Initiates Phase Ib/IIa Trial of VES001 for Frontotemporal Dementia (FTD) with GRN Mutations
10个月前
Vesper Bio's VES001 Shows 95% Increase in Progranulin Levels in Phase Ib/IIa Trial for Frontotemporal Degeneration
去年
Vesper Bio's VES001 Shows Promise in Phase 1 Trial for Frontotemporal Dementia
第 1 页,共 492 页
上一页
下一页